Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_00988 |
| Species: | Homo sapiens |
| Position : | chr6:142706180-142706230 |
| Year: | 2019 |
| Title: | Whole-genome sequencing identifies ADGRG6 enhancer mutations and FRS2 duplications as angiogenesis-related drivers in bladder cancer |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | bladder carcinoma |
| PMID: | 30755618 |
| MONDO: | MONDO:0005094 |
| Tissue: | Bladder |
| Tissue Ontology ID: | UBERON:0001255 |
| Cell Source: | SW780 |
| CVCL ID: | CVCL_1729 |
| Cell Type: | bladder carcinoma cell |
| Cell Ontology ID: | CL:0000066 |
| Experiment Type: | Enhancer activity assay, Functional perturbation assay |
| High Throughput Method: | RNA-seq |
| Low Throughput Method: | RT-RT-qPCR, Western blot |
| Target gene : | ADGRG6 |
| TF name : |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|